SANDOZ GRUP SA 1.K. URUNLERI

Company Type: Manufacturer (Factory)

Company Introduction:

SANDOZ GRUP SA 1.K. URUNLERI represents the operations of Sandoz in Turkey. Sandoz is a global leader in generic and biosimilar medicines, and a division of the Novartis Group. As a major pharmaceutical company, Sandoz is primarily engaged in the research, development, manufacturing, and distribution of a broad portfolio of high-quality, affordable generic drugs, biosimilars, and differentiated products. Their activities in Turkey encompass local manufacturing, sales, and marketing of these pharmaceutical products, contributing significantly to the Turkish healthcare market by providing access to essential medicines. The company is committed to advancing access to medicine globally.

SANDOZ GRUP SA 1.K. URUNLERI, as part of Sandoz, a global leader in generic pharmaceuticals and biosimilars, manufactures and sells a wide range of pharmaceutical products. Their portfolio primarily includes:

Generic Medicines

These are off-patent versions of original branded drugs, covering numerous therapeutic areas.

Biosimilars

Highly similar versions of existing biologic medicines.

Over-the-Counter OTC Products

A selection of non-prescription medicines for common ailments.

Their products address various therapeutic areas, including but not limited to:

Cardiovascular Diseases

Central Nervous System Disorders

Pain Management

Oncology Cancer Treatments

Respiratory Diseases

Anti-infectives Antibiotics, Antivirals, Antifungals

Gastroenterological Conditions

Metabolic Disorders e.g., Diabetes

Immunology

Dermatology

Ophthalmology Eye Care

Women's Health